Economic benefits of the United States’ AIDS drug assistance Program: A systematic review of cost analyses to guide research and policy priorities

Kathleen A. McManus,Andrew Strumpf,Amy Killelea,Tim Horn,Auntré Hamp,Jessica Keim-Malpass

Preventive Medicine Reports（2022）

引用 1|浏览3

暂无评分

摘要

•The AIDS Drug Assistance Program (ADAP) is a $2.4 billion a year program.•Little formal economic analysis of the ADAP in the literature.•The few economic analyses of ADAP use 2008 or older data.•ADAP programs’ healthcare delivery have changed substantially since 2008.•Updated person-centered cost effectiveness models assessing ADAP are needed.

查看译文

关键词

HIV,AIDS Drug Assistance Program,Medication Access,Health Policy,Economic Evaluation,Cost Effectiveness

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要